Provectus Pharmaceuticals inks $1 million
Provectus Pharmaceuticals, a biotech company developing oncology and dermatology drugs, has inked a $1 million investment from Chicago-based Lincoln Park Capital Fund.
PENSRUS, which sells more than10 million custom logo pens each year, is penning the Parker IM the ultimate affordable luxury pen.